Genscript Biotech Corp (2945)

Currency in HKD
33.90
0.00(0.00%)
Closed·

2945 Financial Summary

Key Ratios

P/E Ratio-18.51
Price/Book3.04
Debt / Equity8.82%
Return on Equity-15.33%
Dividend Yield0.00%
EBITDA317.61M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2024
31/12
2025
31/12
* In Millions of USD (except for per share items)

Earnings

Latest Release
Sep 16, 2026
EPS / Forecast
-0.06 / --
Revenue / Forecast
404.22M / --
EPS Revisions
Last 90 days

FAQ

What were Genscript Biotech's earnings for the latest quarter?

The Genscript Biotech EPS (TTM) is -2.29. Genscript Biotech reported sales of 404.22 million USD, net income of -129.34 million USD, and EPS of -0.06 for the latest quarter.

What was Genscript Biotech's net income for the latest quarter?

Genscript Biotech's net income for the latest quarter was -129.34 million USD.

How did Genscript Biotech's performance compare year-over-year in the latest quarter?

The company's revenue moved from 440.75 million USD in the previous quarter to 404.22 million USD in the latest quarter, and net income moved from -507.37 million USD to -129.34 million USD compared to the previous quarter.

What is Genscript Biotech's net profit margin on a TTM basis?

Genscript Biotech's trailing twelve months (TTM) net profit margin is -75.35%.

How does Genscript Biotech's debt to equity ratio compare to industry standards?

Genscript Biotech's total debt-to-equity ratio is 8.82%.

What is Genscript Biotech's return on investment on a TTM basis?

Genscript Biotech's trailing twelve months (TTM) return on investment (ROI) is -15.33%.

How has Genscript Biotech's total revenue grown this year?

Genscript Biotech's total revenue was 440.75 million USD in the previous quarter and 404.22 million USD in the latest quarter.

What is Genscript Biotech's gross margin on a TTM basis?

Genscript Biotech's trailing twelve months (TTM) gross margin is 51.99.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.